Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Statistics

Total Valuation

BOM:532531 has a market cap or net worth of INR 96.28 billion. The enterprise value is 112.15 billion.

Market Cap	96.28B
Enterprise Value	112.15B

Important Dates

The last earnings date was Monday, May 18, 2026.

Earnings Date	May 18, 2026
Ex-Dividend Date	Jul 22, 2025

Share Statistics

Current Share Class	92.17M
Shares Outstanding	n/a
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	7.28%
Owned by Institutions (%)	29.90%
Float	56.70M

Valuation Ratios

The trailing PE ratio is 17.31 and the forward PE ratio is 15.37.

PE Ratio	17.31
Forward PE	15.37
PS Ratio	1.98
PB Ratio	3.06
P/TBV Ratio	5.62
P/FCF Ratio	33.83
P/OCF Ratio	13.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.11, with an EV/FCF ratio of 39.41.

EV / Earnings	20.16
EV / Sales	2.31
EV / EBITDA	12.11
EV / EBIT	15.50
EV / FCF	39.41

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.56.

Current Ratio	1.25
Quick Ratio	0.52
Debt / Equity	0.56
Debt / EBITDA	1.90
Debt / FCF	6.18
Interest Coverage	4.05

Financial Efficiency

Return on equity (ROE) is 20.03% and return on invested capital (ROIC) is 13.63%.

Return on Equity (ROE)	20.03%
Return on Assets (ROA)	6.96%
Return on Invested Capital (ROIC)	13.63%
Return on Capital Employed (ROCE)	17.93%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	14.72M
Profits Per Employee	1.68M
Employee Count	3,301
Asset Turnover	0.75
Inventory Turnover	1.35

Taxes

In the past 12 months, BOM:532531 has paid 941.66 million in taxes.

Income Tax	941.66M
Effective Tax Rate	14.08%

Stock Price Statistics

The stock price has increased by +29.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.71%
50-Day Moving Average	1,054.46
200-Day Moving Average	923.11
Relative Strength Index (RSI)	39.37
Average Volume (20 Days)	14,406

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532531 had revenue of INR 48.59 billion and earned 5.56 billion in profits. Earnings per share was 60.34.

Revenue	48.59B
Gross Profit	29.00B
Operating Income	7.23B
Pretax Income	6.69B
Net Income	5.56B
EBITDA	9.25B
EBIT	7.23B
Earnings Per Share (EPS)	60.34

Balance Sheet

The company has 2.13 billion in cash and 17.58 billion in debt, with a net cash position of -15.45 billion.

Cash & Cash Equivalents	2.13B
Total Debt	17.58B
Net Cash	-15.45B
Net Cash Per Share	n/a
Equity (Book Value)	31.49B
Book Value Per Share	337.09
Working Capital	7.18B

Cash Flow

In the last 12 months, operating cash flow was 7.03 billion and capital expenditures -4.18 billion, giving a free cash flow of 2.85 billion.

Operating Cash Flow	7.03B
Capital Expenditures	-4.18B
Depreciation & Amortization	2.02B
Net Borrowing	-2.40B
Free Cash Flow	2.85B
FCF Per Share	n/a

Margins

Gross margin is 59.69%, with operating and profit margins of 14.88% and 11.45%.

Gross Margin	59.69%
Operating Margin	14.88%
Pretax Margin	13.76%
Profit Margin	11.45%
EBITDA Margin	19.04%
EBIT Margin	14.88%
FCF Margin	5.86%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.39%.

Dividend Per Share	4.00
Dividend Yield	0.39%
Dividend Growth (YoY)	60.00%
Years of Dividend Growth	2
Payout Ratio	6.63%
Buyback Yield	-0.17%
Shareholder Yield	0.22%
Earnings Yield	5.78%
FCF Yield	2.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7